Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8096780rdf:typepubmed:Citationlld:pubmed
pubmed-article:8096780lifeskim:mentionsumls-concept:C1522472lld:lifeskim
pubmed-article:8096780lifeskim:mentionsumls-concept:C1882598lld:lifeskim
pubmed-article:8096780lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:8096780lifeskim:mentionsumls-concept:C1413682lld:lifeskim
pubmed-article:8096780lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:8096780lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:8096780lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:8096780lifeskim:mentionsumls-concept:C1705191lld:lifeskim
pubmed-article:8096780lifeskim:mentionsumls-concept:C1552923lld:lifeskim
pubmed-article:8096780lifeskim:mentionsumls-concept:C1552858lld:lifeskim
pubmed-article:8096780lifeskim:mentionsumls-concept:C1551341lld:lifeskim
pubmed-article:8096780lifeskim:mentionsumls-concept:C1552924lld:lifeskim
pubmed-article:8096780lifeskim:mentionsumls-concept:C0056792lld:lifeskim
pubmed-article:8096780lifeskim:mentionsumls-concept:C0205155lld:lifeskim
pubmed-article:8096780lifeskim:mentionsumls-concept:C0047123lld:lifeskim
pubmed-article:8096780lifeskim:mentionsumls-concept:C0049860lld:lifeskim
pubmed-article:8096780lifeskim:mentionsumls-concept:C0813872lld:lifeskim
pubmed-article:8096780pubmed:issue3lld:pubmed
pubmed-article:8096780pubmed:dateCreated1993-5-13lld:pubmed
pubmed-article:8096780pubmed:abstractText1. The regional binding of [3H]-(+)-5-methyl-10,11-dihydro-5H-dibenzo (a,d)cyclohepten-5,10-imine maleate ([3H]-(+)-MK 801) to sections of rat brain was measured by an in vitro quantitative autoradiographic technique. A heterogeneous distribution of binding sites was observed. 2. High values of binding were detected in the hippocampal formation and cerebral cortex, while very low binding was found in cerebellum. [3H]-(+)-MK 801 binding was not detectable in white matter tracts or in the brain stem. 3. [3H]-(+)-MK 801 binding was inhibited by increasing concentrations of both 7-chlorokynurenate (1-1000 microM) and ((+)-2-carboxypiperazine-4-yl)propyl-1-phosphonic acid (CPP) (0.1-100 microM). High concentrations of both drugs were able to inhibit completely specific [3H]-(+)-MK 801 binding. 4. IC50 values calculated for both 7-chlorokynurenate and CPP-induced [3H]-(+)-MK 801 binding inhibition were similar in all brain regions analyzed. 5. The inhibitory action of 7-chlorokynurenate and that of CPP on [3H]-(+)-MK 801 binding were reversed by addition of glycine and glutamate respectively. 6. It is concluded that activation of glycine and N-methyl-D-aspartate (NMDA) receptors is obligatory for the binding of [3H]-(+)-MK 801 to occur in all of the brain regions examined in the present study. Furthermore, on the basis of the similar regional sensitivities of [3H]-(+)-MK 801 binding to the inhibitory action of 7-chlorokynurenate and CPP, a single pharmacological classification of the NMDA receptor complex in brain is suggested. The cerebellum was not included in the study due to the very low level of [3H]-(+)-MK 801 binding detected under the experimental conditions used.lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:languageenglld:pubmed
pubmed-article:8096780pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:citationSubsetIMlld:pubmed
pubmed-article:8096780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096780pubmed:statusMEDLINElld:pubmed
pubmed-article:8096780pubmed:monthMarlld:pubmed
pubmed-article:8096780pubmed:issn0007-1188lld:pubmed
pubmed-article:8096780pubmed:authorpubmed-author:BoweryN GNGlld:pubmed
pubmed-article:8096780pubmed:authorpubmed-author:TacconeWWlld:pubmed
pubmed-article:8096780pubmed:authorpubmed-author:RattiEElld:pubmed
pubmed-article:8096780pubmed:authorpubmed-author:GaviraghiGGlld:pubmed
pubmed-article:8096780pubmed:authorpubmed-author:MarienM RMRlld:pubmed
pubmed-article:8096780pubmed:issnTypePrintlld:pubmed
pubmed-article:8096780pubmed:volume108lld:pubmed
pubmed-article:8096780pubmed:ownerNLMlld:pubmed
pubmed-article:8096780pubmed:authorsCompleteYlld:pubmed
pubmed-article:8096780pubmed:pagination577-82lld:pubmed
pubmed-article:8096780pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:8096780pubmed:meshHeadingpubmed-meshheading:8096780-...lld:pubmed
pubmed-article:8096780pubmed:meshHeadingpubmed-meshheading:8096780-...lld:pubmed
pubmed-article:8096780pubmed:meshHeadingpubmed-meshheading:8096780-...lld:pubmed
pubmed-article:8096780pubmed:meshHeadingpubmed-meshheading:8096780-...lld:pubmed
pubmed-article:8096780pubmed:meshHeadingpubmed-meshheading:8096780-...lld:pubmed
pubmed-article:8096780pubmed:meshHeadingpubmed-meshheading:8096780-...lld:pubmed
pubmed-article:8096780pubmed:meshHeadingpubmed-meshheading:8096780-...lld:pubmed
pubmed-article:8096780pubmed:meshHeadingpubmed-meshheading:8096780-...lld:pubmed
pubmed-article:8096780pubmed:meshHeadingpubmed-meshheading:8096780-...lld:pubmed
pubmed-article:8096780pubmed:meshHeadingpubmed-meshheading:8096780-...lld:pubmed
pubmed-article:8096780pubmed:meshHeadingpubmed-meshheading:8096780-...lld:pubmed
pubmed-article:8096780pubmed:meshHeadingpubmed-meshheading:8096780-...lld:pubmed
pubmed-article:8096780pubmed:meshHeadingpubmed-meshheading:8096780-...lld:pubmed
pubmed-article:8096780pubmed:meshHeadingpubmed-meshheading:8096780-...lld:pubmed
pubmed-article:8096780pubmed:meshHeadingpubmed-meshheading:8096780-...lld:pubmed
pubmed-article:8096780pubmed:year1993lld:pubmed
pubmed-article:8096780pubmed:articleTitleInhibition of [3H]-(+)-MK 801 binding to rat brain sections by CPP and 7-chlorokynurenic acid: an autoradiographic analysis.lld:pubmed
pubmed-article:8096780pubmed:affiliationGlaxo Research Laboratories, Verona, Italy.lld:pubmed
pubmed-article:8096780pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8096780pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8096780lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8096780lld:pubmed